US2215233A
(en)
|
1937-11-13 |
1940-09-17 |
Simon L Ruskin |
Iron compound of nucleotides and their organic hydrolytic decomposition products and method of making same
|
US3906092A
(en)
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US3911117A
(en)
|
1971-12-20 |
1975-10-07 |
Fredrik Ender |
Raw fish and iron chelated with glutamic or ribonucleic acid in a mink diet
|
US3914450A
(en)
|
1973-04-09 |
1975-10-21 |
Anheuser Busch |
Concentrated extract of yeast and processes of making same
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
DE3280400D1
(en)
|
1981-10-23 |
1992-06-04 |
Molecular Biosystems Inc |
OLIGONUCLEOTIDES MEDICINE AND THEIR PRODUCTION METHOD.
|
US5023243A
(en)
*
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
ES507187A0
(en)
|
1981-11-16 |
1983-01-01 |
Union Ind Y Agro Ganader S A U |
PROCEDURE FOR OBTAINING AN ADDITIONAL HUMANIZED MILK OF NUCLEOTIDES FOR CHILD FEEDING.
|
JPS60126220A
(en)
*
|
1983-12-09 |
1985-07-05 |
Otsuka Pharmaceut Factory Inc |
Nucleic acid component composition
|
US4741914A
(en)
*
|
1984-11-13 |
1988-05-03 |
Ajinomoto Co., Inc. |
Flavor enhancing seasoning containing deodorized garlic extract and process
|
US4956296A
(en)
|
1987-06-19 |
1990-09-11 |
Genex Corporation |
Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
|
JPS62275667A
(en)
*
|
1986-05-22 |
1987-11-30 |
Ajinomoto Co Inc |
Production of seasoning with good body or food with enhanced good body
|
US4950652A
(en)
|
1987-03-23 |
1990-08-21 |
Hem Research, Inc. |
dsRNAs for combination therapy in the treatment of viral diseases
|
US4963387A
(en)
|
1987-05-20 |
1990-10-16 |
Chugai Seiyaku Kabushiki Kaisha |
Salt substitute and foodstuffs containing same
|
ES2007350A6
(en)
|
1987-05-29 |
1989-06-16 |
Ganadera Union Ind Agro |
Food products enriched with nucleosides and/or nucleotides and preparation thereof.
|
CA1339596C
(en)
|
1987-08-07 |
1997-12-23 |
New England Medical Center Hospitals, Inc. |
Viral expression inhibitors
|
US5268365A
(en)
|
1988-03-11 |
1993-12-07 |
Rudolph Frederick B |
Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
|
CA1336174C
(en)
*
|
1988-07-22 |
1995-07-04 |
Ronald Peter Potman |
Method for the preparation of a yeast extract said yeast extract, its use as a food flavour and a food composition comprising the yeast extract
|
US5231085A
(en)
*
|
1988-10-31 |
1993-07-27 |
Sandoz Ltd. |
Compositions and methods for the enhancement of host defense mechanisms
|
US5786189A
(en)
*
|
1989-11-29 |
1998-07-28 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine
|
US5248670A
(en)
|
1990-02-26 |
1993-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides for inhibiting herpesviruses
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
US5234811A
(en)
*
|
1991-09-27 |
1993-08-10 |
The Scripps Research Institute |
Assay for a new gaucher disease mutation
|
US6022853A
(en)
*
|
1991-08-30 |
2000-02-08 |
Creative Biomolecules, Inc. |
Morphogen-enriched dietary composition
|
EP0633929B1
(en)
|
1992-04-01 |
2004-03-03 |
The Rockefeller University |
METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS
|
EP0572735B1
(en)
|
1992-06-04 |
1998-11-25 |
VYSIS, Inc. |
Nucleic acid probes for the detection of Mycoplasma fermentans
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
JPH08504570A
(en)
|
1992-10-05 |
1996-05-21 |
ハイブライドン インコーポレイテッド |
Therapeutic anti-HIV oligonucleotides and drugs
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
WO1995001097A1
(en)
*
|
1993-06-30 |
1995-01-12 |
Board Of Regents, The University Of Texas System |
Nucleotide preparation and uses thereof in wound healing
|
US5804566A
(en)
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
US5849719A
(en)
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
US5700590A
(en)
|
1994-01-10 |
1997-12-23 |
Abbott Laboratories |
Nutritional formula with ribo-nucleotides
|
US5492899A
(en)
*
|
1994-01-10 |
1996-02-20 |
Abbott Laboratories |
Infant nutritional formula with ribo-nucleotides
|
US5488039A
(en)
*
|
1994-01-10 |
1996-01-30 |
Abbott Laboratories |
Method for the production of an enteral formula containing ribo-nucleotides
|
US5602109A
(en)
*
|
1994-01-10 |
1997-02-11 |
Abbott Laboratories |
Method to enhance the immune system of a human
|
DE69517836T2
(en)
|
1994-03-18 |
2001-03-01 |
Ajinomoto Kk |
Protein-containing agent to improve the taste quality of food
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
CA2194761C
(en)
*
|
1994-07-15 |
2006-12-19 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030050263A1
(en)
*
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US5591721A
(en)
*
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US5614191A
(en)
*
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US6428788B1
(en)
|
1995-03-15 |
2002-08-06 |
Penn State University |
Compositions and methods for specifically targeting tumors
|
JP3580900B2
(en)
|
1995-04-20 |
2004-10-27 |
ホクレン農業協同組合連合会 |
Food and feed containing, as an active ingredient, a composition mainly comprising a sugar containing an α-glucosidase inhibitor
|
US5612060A
(en)
*
|
1995-05-25 |
1997-03-18 |
Alexander; J. Wesley |
Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
|
US5976580A
(en)
|
1995-06-07 |
1999-11-02 |
Novus International, Inc. |
Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
US20030219752A1
(en)
|
1995-12-07 |
2003-11-27 |
Diversa Corporation |
Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
|
GB9525902D0
(en)
|
1995-12-16 |
1996-02-21 |
Zeneca Ltd |
Fungus
|
EP0879284B1
(en)
*
|
1996-01-30 |
2009-07-29 |
The Regents of The University of California |
Gene expression vectors which generate an antigen specific immune response and methods of using the same
|
US20030078223A1
(en)
*
|
1996-01-30 |
2003-04-24 |
Eyal Raz |
Compositions and methods for modulating an immune response
|
US5895652A
(en)
*
|
1996-07-29 |
1999-04-20 |
Longevity Institute International |
Method of metabolic adjuvanation and cellular repair
|
ATE292980T1
(en)
|
1996-10-11 |
2005-04-15 |
Univ California |
IMMUNO-STIMULATING OLIGONUCLEOTIDE CONJUGATES
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
WO1998037919A1
(en)
*
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
CA2286210A1
(en)
|
1997-04-18 |
1998-10-29 |
Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) |
Attenuated salmonella strain used as a vehicle for oral immunization
|
US20030104044A1
(en)
*
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
EP1003531B1
(en)
*
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
CA2291483C
(en)
*
|
1997-06-06 |
2012-09-18 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US20040006034A1
(en)
*
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6589940B1
(en)
*
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US5922766A
(en)
*
|
1997-07-02 |
1999-07-13 |
Acosta; Phyllis J. B. |
Palatable elemental medical food
|
EP1009413B1
(en)
|
1997-09-05 |
2007-02-14 |
The Regents Of The University Of California |
Use of immunostimulatory oligonucleotides for preventing or treating asthma
|
ES2284247T3
(en)
*
|
1998-04-03 |
2007-11-01 |
University Of Iowa Research Foundation |
METHODS AND PRODUCTS TO STIMULATE THE IMMUNITY SYSTEM USING OLIGONUCLEOTIDES AND IMMUNOTHERAPEUTIC CYTOQUINS.
|
PL345241A1
(en)
|
1998-05-06 |
2001-12-03 |
Upjohn Co |
Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
|
US7227011B2
(en)
*
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US20010034330A1
(en)
|
1998-08-10 |
2001-10-25 |
Charlotte Kensil |
Innate immunity-stimulating compositions of CpG and saponin and methods thereof
|
EP1832657B1
(en)
|
1998-09-09 |
2012-10-24 |
Genzyme Corporation |
Methylation of plasmid vectors
|
US20020065236A1
(en)
*
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
US20020142974A1
(en)
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
DE69931377T2
(en)
*
|
1998-09-18 |
2007-05-10 |
Dynavax Technologies Corp., Berkeley |
PROCESS FOR TREATING IG-E ASSOCIATED DISEASES AND COMPOSITIONS FOR USE THEREOF IN THESE METHODS
|
CA2359636A1
(en)
*
|
1999-01-22 |
2000-07-27 |
Andrew W. Taylor |
Activation of regulatory t cells by alpha-melanocyte stimulating hormone
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US6710173B1
(en)
*
|
1999-06-25 |
2004-03-23 |
Progenics Pharmaceuticals, Inc. |
Stabilized viral envelope proteins and uses thereof
|
DE60023300T2
(en)
|
1999-06-29 |
2006-07-06 |
Glaxosmithkline Biologicals S.A. |
USE OF CPG AS ADJUVANS FOR HIV PULP
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
AP1775A
(en)
*
|
1999-09-25 |
2007-08-28 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids.
|
US20020091095A1
(en)
*
|
1999-12-13 |
2002-07-11 |
Phillips Nigel C. |
Modulation of Fas and FasL expression
|
US20020006403A1
(en)
*
|
1999-12-14 |
2002-01-17 |
Xue-Zhong Yu |
CD28-specific antibody compositions for use in methods of immunosuppression
|
ATE378348T1
(en)
*
|
2000-01-14 |
2007-11-15 |
Us Health |
OLIGODEOXYNUCLEOTIDES AND THEIR USE FOR INDUCING AN IMMUNE RESPONSE
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
AT409085B
(en)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
PHARMACEUTICAL COMPOSITION FOR IMMUNULATING AND PRODUCING VACCINES
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
US20030130217A1
(en)
*
|
2000-02-23 |
2003-07-10 |
Eyal Raz |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
EP1259264A4
(en)
|
2000-02-23 |
2005-08-31 |
Univ California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
AU2001239873A1
(en)
*
|
2000-02-24 |
2001-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant treatment by in vivo activation of dendritic cells
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US20030129251A1
(en)
*
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7129222B2
(en)
*
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20020107212A1
(en)
*
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20020028784A1
(en)
*
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
AU2001249609A1
(en)
*
|
2000-03-28 |
2001-10-08 |
Department Of Veterans Affairs |
Methods for increasing a cytotoxic T lymphocyte response in vivo
|
EP1278550A4
(en)
|
2000-04-07 |
2004-05-12 |
Univ California |
Synergistic improvements to polynucleotide vaccines
|
GB0009470D0
(en)
|
2000-04-17 |
2000-06-07 |
Univ Southampton |
Materials and methods relating to immune responses to fusion proteins
|
US6893821B2
(en)
|
2000-05-05 |
2005-05-17 |
The Regents Of The University Of California |
Agents that modulate DNA-PK activity and methods of use thereof
|
US6593511B1
(en)
*
|
2000-05-12 |
2003-07-15 |
Bioseek, Inc. |
Models of chronic and acute inflammatory diseases
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
KR100799788B1
(en)
|
2000-06-08 |
2008-01-31 |
인터셀 아게 |
Immunostimulatory oligodeoxynucleotides
|
WO2001097843A2
(en)
*
|
2000-06-22 |
2001-12-27 |
University Of Iowa Research Foundation |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
JP5511117B2
(en)
|
2000-07-27 |
2014-06-04 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
Vaccine for broad protection against diseases caused by Neisseria meningitidis
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
US7318928B2
(en)
*
|
2000-08-01 |
2008-01-15 |
The Johns Hopkins University |
Molecular vaccine linking intercellular spreading protein to an antigen
|
US7811592B2
(en)
|
2000-08-16 |
2010-10-12 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
|
IL154557A0
(en)
*
|
2000-08-25 |
2003-09-17 |
Yeda Res & Dev |
Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide
|
US20020091097A1
(en)
*
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
WO2002022809A2
(en)
*
|
2000-09-15 |
2002-03-21 |
Coley Pharmaceutical Gmbh |
PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
|
WO2002026757A2
(en)
|
2000-09-26 |
2002-04-04 |
Hybridon, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
ES2260291T3
(en)
*
|
2000-09-28 |
2006-11-01 |
Chiron Corporation |
MICROPARTICLES FOR THE ADMINISTRATION OF HETEROLOGICAL NUCLEIC ACIDS.
|
CN101428006A
(en)
|
2000-09-28 |
2009-05-13 |
诺华疫苗和诊断公司 |
Microparticle compositions and methods for the manufacture thereof
|
AU2002228932A1
(en)
*
|
2000-10-24 |
2002-05-06 |
Schering Corporation |
Maturation of dendritic cells
|
KR100331952B1
(en)
|
2000-11-23 |
2002-04-09 |
최수일 |
The Composition Of Multipurpose High-Functional Alkali Solution, Preparation Thereof, And For The Use Of Nonspecific Immunostimulator
|
EP1985702A3
(en)
|
2000-12-08 |
2010-08-18 |
Coley Pharmaceutical GmbH |
CPG-like nucleic acids and methods of use thereof
|
AU2002248185A1
(en)
*
|
2000-12-14 |
2002-07-16 |
Coley Pharmaceutical Group, Inc. |
Inhibition of angiogenesis by nucleic acids
|
US20030185848A1
(en)
|
2000-12-15 |
2003-10-02 |
Board Of Regents, The University Of Texas System |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia psittaci
|
EP1364010B1
(en)
*
|
2000-12-27 |
2010-06-16 |
Dynavax Technologies Corporation |
Immunomodulatory polynucleotides and methods of using the same
|
US20030050268A1
(en)
*
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
CA2439428C
(en)
*
|
2001-04-17 |
2012-01-24 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
|
US20030096417A1
(en)
*
|
2001-06-01 |
2003-05-22 |
Fischer Laurent Bernard |
Vaccination against feline immunodeficiency virus
|
US7785610B2
(en)
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US7547551B2
(en)
*
|
2001-06-21 |
2009-06-16 |
University Of Antwerp. |
Transfection of eukaryontic cells with linear polynucleotides by electroporation
|
EP2423335B1
(en)
|
2001-06-21 |
2014-05-14 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same
|
US7666674B2
(en)
*
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
AU2002318944A1
(en)
|
2001-08-01 |
2003-02-17 |
Coley Pharmaceutical Gmbh |
Methods and compositions relating to plasmacytoid dendritic cells
|
EP1501359A4
(en)
*
|
2001-08-03 |
2007-04-18 |
Celldex Therapeutics Inc |
Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
|
US20030133988A1
(en)
*
|
2001-08-07 |
2003-07-17 |
Fearon Karen L. |
Immunomodulatory compositions, formulations, and methods for use thereof
|
US7604955B2
(en)
*
|
2001-08-13 |
2009-10-20 |
Swey-Shen Alex Chen |
Immunoglobulin E vaccines and methods of use thereof
|
AU2002361468A1
(en)
*
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
SG177000A1
(en)
|
2001-08-17 |
2012-01-30 |
Coley Pharm Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
AU2002324909A1
(en)
|
2001-09-07 |
2003-03-24 |
Baylor College Of Medicine |
Linear dna fragments for gene expression
|
US20030119774A1
(en)
*
|
2001-09-25 |
2003-06-26 |
Marianna Foldvari |
Compositions and methods for stimulating an immune response
|
AR045702A1
(en)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
COMPOSITIONS OF ASSISTANTS.
|
BR0213097A
(en)
|
2001-10-05 |
2005-02-01 |
Coley Pharm Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
US20030139364A1
(en)
*
|
2001-10-12 |
2003-07-24 |
University Of Iowa Research Foundation |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
US7544669B2
(en)
|
2001-11-21 |
2009-06-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polynucleotide therapy
|
TW200303759A
(en)
*
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
US8466116B2
(en)
*
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
CA2388049A1
(en)
*
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
US20040009949A1
(en)
*
|
2002-06-05 |
2004-01-15 |
Coley Pharmaceutical Group, Inc. |
Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids
|
AU2003267986A1
(en)
*
|
2002-07-03 |
2004-01-23 |
Depuy Mitek, Inc. |
Vaccines to induce mucosal immunity
|
NZ538628A
(en)
*
|
2002-08-12 |
2008-06-30 |
Dynavax Tech Corp |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
US7758876B2
(en)
*
|
2002-11-01 |
2010-07-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
US7560436B2
(en)
*
|
2005-02-22 |
2009-07-14 |
The Regents Of The University Of California |
Methods of treating gastrointestinal inflammation
|
AU2006325225B2
(en)
*
|
2005-12-14 |
2013-07-04 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|